Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 16 17 18 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Thermosome–SEVERAL: investment, 201604 1st financing round €1.9m from HTGF + Bayern Kapital + private investors 2016-04-06
Qiagen–BioTeam: bioinformatics, 201604 collab existent to create high-performance appliance with CLC Genomics Server + BioTeam Appliance platform 2016-04-05
Qiagen–Intel: bioinformatics, 201604 collab existent to develop reference architecture for high-volume whole genome data analysis 2016-04-05
Anergis–SEVERAL: investment, 201604 financing round extension CHF5m to conduct phase 2b study with AllerT from existing investors 2016-04-04
Immunocore–Medigene: investment, 201604 DIVESTMENT sale of 50% of Medigene’s stake in Immunocore for £4.9m (€6.1m) 2016-04-04
Metabomed–Boehringer: investment, 201604 financing round Series A totalling $18m incl investors MS Ventures + BIVF et al 2016-04-04
Metabomed–Merck (DE): investment, 201604 financing round Series A totalling $18m incl investors MS Ventures + BIVF et al 2016-04-04
Metabomed–SEVERAL: investment, 201604 financing round Series A extension bringing total Series A round to close with $18m 2016-04-04
Fusion Antibodies–MAB Discovery: antibody technology, 201603– collab + license use CDRx humanisation w rabbit-based MAb technology for therap MAbs 2016-03-31
NEO New Oncology–Siemens: investment, 201603 acquisiton by Siemens Healthcare GmbH 2016-03-31
Amal Therapeutics–Boehringer: investment, 201603 financing round Series A totalling CHF3m incl lead investor BIVF 2016-03-30
Amal Therapeutics–High-Tech Gründerfonds: investment, 201603 financing round Series A totalling CHF3m incl co-investor HTGF 2016-03-30
Amal Therapeutics–Instinctif Partners: public relations, 201603 service existent by Instinctif Partners 2016-03-30
Amal Therapeutics–SEVERAL: investment, 201603 financing round Series A CHF3m led by BIVF with co-investors VI Partners + HTGF 2016-03-30
Amal Therapeutics–VI Partners: investment, 201603 financing round Series A totalling CHF3m incl co-investor VI Partners 2016-03-30
BioChain–Epigenomics: molecular diagnostics, 201603– license excl blood-based lung cancer test for developm + commercialisation in China 2016-03-30
Zavante Therapeutics–SEVERAL: investment, 201603 financing round Series A $45m with $35m from new investors + $10m conversion of convertible notes 2016-03-30
Exiqon–Qiagen: investment, 201603–201606 conditional voluntary takeover offer DKK683m ($100m) 2016-03-29
Gadeta–SEVERAL: investment, 201603 financing round Series A €7m led by Medicxi Ventures + Baxalta Ventures with Utrecht Holdings + founders + managers 2016-03-29
ABBA Therapeutics–Ligand: transgenic animal technology, 201603– license to use OmniAb platform to develop MAbs + bi-specific ABs 2016-03-28
Bayer–Holta Invest: investment, 201603 existent Bayer listed as portfolio company of Holta Life Sciences 2016-03-28
Roche–Holta Invest: investment, 201603 existent Roche listed as portfolio company of Holta Life Sciences 2016-03-28
Diatron–Stratec: investment, 201603 acquisition 100% of Diatron MI PLC by Stratec from The Riverside Company 2016-03-23
Padlock Therapeutics–BMS: investment, 201603–201604 acquisition 100% for up to $600m 2016-03-23
Thuringia (govt)–High-Tech Gründerfonds: venture capital, 201603– collab renewed TSF + HTGF to jointly provide up to €3.15m for early financings 2016-03-23
Topas Therapeutics–EMBL: investment, 201603 financing round Series A totalling €14m incl co-investor EMBL Ventures 2016-03-22
Topas Therapeutics–Epidarex Capital: investment, 201603 financing round Series A totalling €14m led by Epidarex 2016-03-22
Topas Therapeutics–Evotec: investment, 201603 financing round Series A totalling €14m incl co-investor Evotec AG 2016-03-22
Topas Therapeutics–Gimv: investment, 201603 financing round Series A totalling €14m incl €4m from co-investor Gimv Health & Care 2016-03-22
Topas Therapeutics–SEVERAL: investment, 201603 financing round Series A €14m led by Epidarex incl EMBL Ventures + Gimv + Evotec 2016-03-22
GSK–Miltenyi Biotec: cell/gene therapy, 201603– collab cell + gene therapy incl CAR-T using increased automation 2016-03-16
SkyePharma–Vectura: investment, 201603– acquisition merger £441m in shares (up to £70m cash) resulting in 41.75% (37.62%) for former Skye owners 2016-03-16
Almirall–Grünenthal: investment, 201603– acquisition 100% of Almirall de Mexico SA de CV by Grünenthal ANNNOUNCED 2016-03-15
Bohui–Univ Freiburg: mass spec sample introduction technique, –201603 collab developm iASAP Prof Krossing + license of patent rights to Advion 2016-03-15
Roche–Blueprint Medicines: kinase inhibitors, 201603– collab ww $45m upfront + $965m milestones r+d + commerc up to 5 small molelcule drugs 2016-03-15
eTheRNA–Boehringer: investment, 201603 financing round Series A totalling €24m incl co-investor BIVF 2016-03-14
eTheRNA–Flanders (govt): investment, 201603 financing round Series A totalling €24m led by PMV + Life Sciences Partners 2016-03-14
eTheRNA–Fund+: investment, 201603 financing round Series A totalling €24m incl co-investor Fund+ 2016-03-14
eTheRNA–Life Sciences Partners: investment, 201603 financing round Series A totalling €24m led by Life Sciences Partners + PMV 2016-03-14
eTheRNA–Omega Advisors: investment, 201603 financing round Series A totalling €24m incl co-investor Omega Funds 2016-03-14
eTheRNA–SEVERAL: investment, 201603 financing round Series A €24m led by Life Sciences Partners + PMV 2016-03-14
Agilent–Eurofins: genomic technology, 201603– collab Eurofins Genomics supplies custom components for Agilent’s SureVector cloning kits 2016-03-10
Aprea–MC Services: public relations, 201602 service existent for Aprea AB 2016-03-09
AbbVie–Boehringer: therap antibodies, 201603– collab + acqu ww rights BI 655066 + BI 655064 for $595m upfront + undisclosed milestones + royalties 2016-03-07
Argos–SEVERAL: investment, 201603– securities purchase agreem up to $60m common stock + warrants in 3 tranches incl Pharmstandard + TVM 2016-03-07
ITM Isotopen Technologien München–OTHER: investment, 201603 equity investment €20m from Medtech-focused family office 2016-03-07
Biocom–Nasdaq OMX: press release distribution, 201603 collab existent integration of channel news in Eurobiotechnews.eu portal 2016-03-06
Snowy Range Instruments–Metrohm: investment, 201603 acquisition of majority by Metrohm + SnRI renamed Metrohm Raman 2016-03-04
Biolink (NO)–Evonik: investment, 201603 acquisition €na of MedPalett AS by Evonik from Biolink Group 2016-03-03
Grünenthal–Axxam: drug discovery services, 201603– collab to discover small moleucule lead structures to treat pain + inflammation 2016-03-03
Pulsar Photonics–High-Tech Gründerfonds: investment, 201603 seed financing from HTGF 2016-03-02
Cycle GmbH–Hamburg (govt): investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–High-Tech Gründerfonds: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–PERSON: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–SEVERAL: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Merck (DE)–EMBL: drug discovery, 201603–201902 collab research 3y with EMBL Heidelberg w focus on cancer metabolism 2016-03-01
Retina Implant–SEVERAL: investment, 201602 private equity funding round €26m from existing + new investors 2016-02-29
CPGR (ZA)–Thermo Fisher: mass spectrometer, 201602 supply existent Q Exactive MS system used for proteomics 2016-02-26
Blue Scientific–Accurion: laboratory instruments, 201602– distribution Nanofilm Technology + Halcyonics products in UK + Nordics by Blue Scientific 2016-02-25
Pronutria–Nestlé: investment, 201602 equity investment $42.5m by Nestlé Health Science 2016-02-23
Ergomed–MC Services: public relations, 201602 service existent for Ergomed plc 2016-02-18
MorphoSys–MC Services: public relations, 201602 service existent for MorphoSys AG 2016-02-18
Newron–MC Services: public relations, 201602 service existent for Newron Pharmaceuticals 2016-02-18
Strüngmann Group–MC Services: public relations, 201602 service existent for AiCuris Anti-infective Cures GmbH 2016-02-18
Transcend Medical–Novartis: investment, 201602 acquisition €na by Alcon 2016-02-18
Ipsen–3B Pharmaceuticals: radiopharmaceutical, 201602– license ww excl for radiopharmaceuticals in oncology 2016-02-17
Saphetor–Capricorn One: public relations, 201602 service existent for Saphetor SA 2016-02-17
Saphetor–SEVERAL: investment, 201602 seed financing round CHF1.2m from undisclosed investors 2016-02-17
Venture Valuation–Nasdaq OMX: press release distribution, 201602– collab integration of channel news in Biotechgate online directories 2016-02-17
Apogenix–Germany (govt): grant, 201602 BMBF grant €3m for developm of companion diagnostic w R-Biopharm for APG101 in glioblastoma 2016-02-16
Merck (DE)–Weizmann Institute: life sciences, 201602– collab 3y framework agreement research 2016-02-16
Novartis–Pfizer: biosimilar, 201602– Sandoz acquires rights to PF-06438179 (infliximab) in EEA which Pfizer had to divest after Hospira acquisition 2016-02-12
Curetis–Degroof Petercam: financial services, 201602– supply service liquidity provider to facilitate share trading on Euronext Brussels + Amsterdam 2016-02-11
Armo BioSciences–HBM: investment, 201602 private financing round Series C totalling $50m incl $10m from new investor HBM Healthcare Investments 2016-02-10
Armo BioSciences–SEVERAL: investment, 201602 private financing round Series C $50m from existent + new investors 2016-02-10
Hemovent–SEVERAL: investment, 201602 financing round Series A $6m led by MIG Verwaltungs AG 2016-02-10
Qiagen–10x Genomics: genomic technology, 201602– collab co-developm + co-marketing of NGS + single-cell biology + bioinformatics solutions 2016-02-09
Sophia Genetics–Swift Biosciences: molecular diagnostics, 201602– collab product integration offering combined MDx solutions in Europe 2016-02-09
Tollys–Riboxx: cancer drug, 201602– license ww excl to Apoxxim TLR3-ligand programme to Tollys 2016-02-04
Univ Rochester–Indivumed: tissue bank, 201602– collab 3y €na to establish UMRC-Indivumed tissue bank for cancer research 2016-02-04
Labiotech.eu–SEVERAL: investment, 201602 seed financing round €6-digit led by WestTech Ventures 2016-02-03
SmartDyeLivery–SEVERAL: investment, 201602 seed financing from bm|t + Sparkasse Jena-Saale-Holzland 2016-02-03
Syngenta–ChemChina: investment, 201602– recommended cash acquisition offer valuing Syngenta at over $43b ANNOUNCED 2016-02-03
Evotec–Michael J Fox Foundation: grant, 201602 research grant for further developm of TargetaSN programme to treat Parkinson’s disease 2016-02-02
Medicxi Ventures–SEVERAL: investment, 201602 closing €210m of MV1 fund incl investments from GSK + JnJ Innovation JJDC 2016-02-02
Mission Therapeutics–Roche: investment, 201602 financing round totalling £60m incl returning co-investor Roche Venture Fund 2016-02-02
Mission Therapeutics–SEVERAL: investment, 201602 financing round £60m led by Imperial Innovations + new investor Woodford PCT 2016-02-02
Qiagen–CosmosID: bioinformatics, 201602– collab integration of CosmosID metagenomics analysis platform in CLC Genomics Workbench 2016-02-02
Alere–Abbott: investment, 201602– acquisition $5.8b equity value with $56/share ANNOUNCED 2016-02-01
InflaRx–MC Services: public relations, 201601 service existent by MC Services AG 2016-01-28
Medigene–Univ Lausanne: TCR technology, 201601– collab €na service by UNIL using NTAmer technology of TCMetrix 2016-01-25
Merck (US)–Affimed: cancer immunotherapy, 201601– collab €na clinical research combining AFM13 w pembrolizumab in Hodgkin lymphoma 2016-01-25
SeNostic–SEVERAL: investment, 201601 seed financing round led by HTGF 2016-01-25
RA-MAP Consortium–Protagen: biomarker discovery, 201601– collab Protagen joins RA-MAP Consortium contributing SeroTag platform for RA biomarker search 2016-01-21
Synoste–Evonik: investment, 201601 financing round Series A single-digit €n from Evonik + HTGF + Finnvera + Lifeline Ventures + business angels 2016-01-21
Synoste–High-Tech Gründerfonds: investment, 201601 financing round Series A single-digit €m from Evonik + HTGF + Finnvera + Lifeline Ventures + angels 2016-01-21
Synoste–SEVERAL: investment, 201601 financing round Series A single-digit €n from Evonik + HTGF + Finnvera + Lifeline Ventures + business angels 2016-01-21
Vasopharm–Hume Brophy: public relations, 201601 service existent by Hume Brophy 2016-01-21
Vasopharm–SEVERAL: investment, 201601 financing round €20m led by HeidelbergCapital + Entrepreneurs Fund + Fort Rock Capital 2016-01-21
City of Hope–Cevec: rec protein production technology, 201601– license €na to CAP GT technology to Beckman Research Institute 2016-01-20
next pagenext page 1 2 3 ... 16 17 18 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top